First impressions matter: early CPAP use predicts future success

IF 9 1区 医学 Q1 RESPIRATORY SYSTEM
Thorax Pub Date : 2025-03-12 DOI:10.1136/thorax-2025-223052
Stephanie K Kim Mansell, Swapna Mandal
{"title":"First impressions matter: early CPAP use predicts future success","authors":"Stephanie K Kim Mansell, Swapna Mandal","doi":"10.1136/thorax-2025-223052","DOIUrl":null,"url":null,"abstract":"Obstructive sleep apnoea (OSA) is a highly prevalent condition affecting 2 billion adults globally.1 The economic burden of OSA has been reported to be in the billions.2 Continuous positive airway pressure (CPAP) remains the gold standard treatment for OSA.3 The clinical and cost-effectiveness of CPAP depend on patients’ adherence to treatment.4 As many clinicians will recognise, CPAP is often a difficult treatment for patients to tolerate, and published data demonstrate that more than one-third of patients are, in the long run, non-concordant with CPAP treatment.5 Many interventions to increase concordance with CPAP therapy have been investigated, including behaviour therapies such as motivational interviewing,6 management of side effects with interventions such as humidification or different interfaces7 and more recently telemedicine and mobile applications.8 While these interventions have been potentially beneficial in clinical trials, transferability to real-world clinical practice is variable. More recently, the timing of interventions to mitigate poor use has been considered with guidelines advocating follow-up after 1 week, 4–6 weeks and 12 weeks after treatment initiation.9 Dielesen et al 10 in their paper have conducted a study to investigate associations between early CPAP use behaviours …","PeriodicalId":23284,"journal":{"name":"Thorax","volume":"99 1","pages":""},"PeriodicalIF":9.0000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thorax","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/thorax-2025-223052","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Obstructive sleep apnoea (OSA) is a highly prevalent condition affecting 2 billion adults globally.1 The economic burden of OSA has been reported to be in the billions.2 Continuous positive airway pressure (CPAP) remains the gold standard treatment for OSA.3 The clinical and cost-effectiveness of CPAP depend on patients’ adherence to treatment.4 As many clinicians will recognise, CPAP is often a difficult treatment for patients to tolerate, and published data demonstrate that more than one-third of patients are, in the long run, non-concordant with CPAP treatment.5 Many interventions to increase concordance with CPAP therapy have been investigated, including behaviour therapies such as motivational interviewing,6 management of side effects with interventions such as humidification or different interfaces7 and more recently telemedicine and mobile applications.8 While these interventions have been potentially beneficial in clinical trials, transferability to real-world clinical practice is variable. More recently, the timing of interventions to mitigate poor use has been considered with guidelines advocating follow-up after 1 week, 4–6 weeks and 12 weeks after treatment initiation.9 Dielesen et al 10 in their paper have conducted a study to investigate associations between early CPAP use behaviours …
第一印象很重要:早期使用CPAP可以预测未来的成功
阻塞性睡眠呼吸暂停(OSA)是一种非常普遍的疾病,影响着全球20亿成年人据报道,阻塞性睡眠呼吸暂停造成的经济负担高达数十亿美元持续气道正压通气(CPAP)仍然是osa的金标准治疗方法。CPAP的临床和成本效益取决于患者对治疗的依从性正如许多临床医生所认识到的那样,CPAP通常是一种患者难以忍受的治疗,并且已发表的数据表明,从长远来看,超过三分之一的患者与CPAP治疗不一致已经研究了许多增加CPAP治疗一致性的干预措施,包括动机访谈等行为疗法,加湿或不同接口等干预措施的副作用管理,以及最近的远程医疗和移动应用虽然这些干预措施在临床试验中具有潜在的益处,但在实际临床实践中的可转移性是可变的。最近,为了减少不良使用,已经考虑了干预措施的时机,指南提倡在治疗开始后1周、4-6周和12周进行随访Dielesen等人在他们的论文中进行了一项研究,调查了早期CPAP使用行为与…
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Thorax
Thorax 医学-呼吸系统
CiteScore
16.10
自引率
2.00%
发文量
197
审稿时长
1 months
期刊介绍: Thorax stands as one of the premier respiratory medicine journals globally, featuring clinical and experimental research articles spanning respiratory medicine, pediatrics, immunology, pharmacology, pathology, and surgery. The journal's mission is to publish noteworthy advancements in scientific understanding that are poised to influence clinical practice significantly. This encompasses articles delving into basic and translational mechanisms applicable to clinical material, covering areas such as cell and molecular biology, genetics, epidemiology, and immunology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信